Cancer Research Meeting Calendar  Genetics and Biology of Brain Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Research 66, 10325, November 1, 2006. doi: 10.1158/0008-5472.CAN-06-1594
© 2006 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhang, J.
Right arrow Articles by Tlsty, T. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhang, J.
Right arrow Articles by Tlsty, T. D.

Molecular Biology, Pathobiology, and Genetics

p16INK4a Modulates p53 in Primary Human Mammary Epithelial Cells

Jianmin Zhang, Curtis R. Pickering, Charles R. Holst, Mona L. Gauthier and Thea D. Tlsty

Department of Pathology and UCSF Comprehensive Cancer Center, University of California San Francisco, San Francisco, California

Requests for reprints: Thea D. Tlsty, Department of Pathology and UCSF Comprehensive Cancer Center, University of California San Francisco, 513 Pamassus Avenue, HSW 451, Box 0511, San Francisco, CA 94143. Phone: 415-502-6115; Fax: 415-502-6163; E-mail: thea.tlsty{at}ucsf.edu.

p16INK4a (p16) and p53 are tumor suppressor genes that are inactivated during carcinogenesis in many tumors. Here we show that p16 gene activity inversely modulates p53 status and function in primary human mammary epithelial cells. Reduced levels of p16 protein stabilize p53 protein through inhibition of proteolytic degradation, and this increase in p53 protein levels enhances the cellular response to radiation, represses proliferation, and transcriptionally activates downstream targets. Stabilization of p53 is mediated through the retinoblastoma/E2F/p14ARF/murine double minute-2 pathway. However, we have observed that p16 does not modulate p53 in fibroblasts, indicating a possible cell type–specific regulation of this pathway. (Cancer Res 2006; 66(21): 10325-31)




This article has been cited by other articles:


Home page
Cancer Res.Home page
J. C. Garbe, S. Bhattacharya, B. Merchant, E. Bassett, K. Swisshelm, H. S. Feiler, A. J. Wyrobek, and M. R. Stampfer
Molecular Distinctions between Stasis and Telomere Attrition Senescence Barriers Shown by Long-term Culture of Normal Human Mammary Epithelial Cells
Cancer Res., October 1, 2009; 69(19): 7557 - 7568.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
L. I. Huschtscha, J. D. Moore, J. R. Noble, H. G. Campbell, J. A. Royds, A. W. Braithwaite, and R. R. Reddel
Normal human mammary epithelial cells proliferate rapidly in the presence of elevated levels of the tumor suppressors p53 and p21WAF1/CIP1
J. Cell Sci., August 15, 2009; 122(16): 2989 - 2995.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
T. Liu, Y. Niu, Y. Yu, Y. Liu, and F. Zhang
Increased {gamma}-tubulin expression and P16INK4A promoter methylation occur together in preinvasive lesions and carcinomas of the breast
Ann. Onc., March 1, 2009; 20(3): 441 - 448.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
W. F. Leong, J. F. L. Chau, and B. Li
p53 Deficiency Leads to Compensatory Up-Regulation of p16INK4a
Mol. Cancer Res., March 1, 2009; 7(3): 354 - 360.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
T. Terzian, Y.-A. Suh, T. Iwakuma, S. M. Post, M. Neumann, G. A. Lang, C. S. Van Pelt, and G. Lozano
The inherent instability of mutant p53 is alleviated by Mdm2 or p16INK4a loss
Genes & Dev., May 15, 2008; 22(10): 1337 - 1344.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2006 by the American Association for Cancer Research.